Targeted siRNA delivery to diseased microvascular endothelial cells-Cellular and molecular concepts

IUBMB Life

Volumn 63, Issue 8, 2011, Pages 648-658

  Kowalski, Piotr S ^a   Leus, Niek G J ^a   Scherphof, Gerrit L ^a   Ruiters, Marcel H J ^a,b   Kamps, Jan A A M ^a   Molema, Grietje ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Synvolux Therapeutics   (Netherlands)

Author keywords

drug delivery; endothelial cells; intracellular release; liposomes; nonviral delivery devices; siRNA; targeted delivery

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LIPID; LIPOPLEX; LIPOSOME; MACROGOL; MESSENGER RNA; POLYMER; SMALL INTERFERING RNA; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD VESSEL REACTIVITY; CELL SUBPOPULATION; CORONARY BLOOD VESSEL; DEVICE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; INFLAMMATION; NONHUMAN; REVIEW; RNA INTERFERENCE; VASCULAR ENDOTHELIUM;

ENDOTHELIUM, VASCULAR; HUMANS; MICROVESSELS; RNA, SMALL INTERFERING;

EID: 79960804251     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.487     Document Type: Review

References (82)

1. Rabelink, T. J., de Boer, H. C., and, van Zonneveld, A. J., (2010) Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat. Rev. Nephrol. 6, 404-414.
2. Pober, J. S., and, Sessa, W. C., (2007) Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803-815. (Pubitemid 47480307)
3. Molema, G., (2010) Endothelial dysfunction and inflammation. In Progress in Inflamation Research, vol. 2 (, Parnharm, M., ed.). pp. 14-35, Springer, Basel.
4. Aird, W. C., (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100, 158-173. (Pubitemid 46208717)
5. Aird, W. C., (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100, 174-190.
6. Molema, G., (2010) Heterogeneity in endothelial responsiveness to cytokines, molecular causes, and pharmacological consequences. Semin. Thromb. Hemost. 36, 246-264.
7. Liu, M., Kluger, M. S., D'Alessio, A., Garcia-Cardena, G., and, Pober, J. S., (2008) Regulation of arterial-venous differences in tumor necrosis factor responsiveness of endothelial cells by anatomic context. Am. J. Pathol. 172, 1088-1099. (Pubitemid 351520005)
8. Langenkamp, E., and, Molema, G., (2009) Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer. Cell Tissue Res. 335, 205-222.
9. Kuldo, J. M., Ogawara, K. I., Werner, N., Asgeirsdottir, S. A., Kamps, J. A., et al. (2005) Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr. Vasc. Pharmacol. 3, 11-39. (Pubitemid 40089525)
10. Huang, R. B., Mocherla, S., Heslinga, M. J., Charoenphol, P., and, Eniola-Adefeso, O., (2010) Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). Mol. Membr. Biol. 27, 190-205.
11. Molema, G., (2008) Targeted drug delivery to the tumor neovasculature: concepts, advances, and challenges. In Angiogenesis: An Integrative Approach From Science to Medicine, Chapter 25 (, Figg, W. D., and, Folkman, J., eds). pp. 283-297, Springer Verlarg, New York.
12. Kamps, J. A. A. M., and, Molema, G., (2007) Targeting liposomes to endothelial cells in inflammatory diseases. In Liposome Technology, vol. 3 (, Gregoriadis, G., ed). pp. 127-150, Informa Healthcare, New York.
13. van Meurs, M., Kurniati, N. F., Wulfert, F. M., Asgeirsdottir, S. A., de Graaf, I. A., et al. (2009) Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am. J. Physiol. Renal Physiol. 297, F272-281.
14. Deosarkar, S. P., Malgor, R., Fu, J., Kohn, L. D., Hanes, J., et al. (2008) Polymeric particles conjugated with a ligand to VCAM-1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis. Biotechnol. Bioeng. 101, 400-407.
15. Scott, R. C., Wang, B., Nallamothu, R., Pattillo, C. B., Perez-Liz, G., et al. (2007) Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction. Biotechnol. Bioeng. 96, 795-802. (Pubitemid 46395947)
16. Asgeirsdottir, S. A., Kamps, J. A., Bakker, H. I., Zwiers, P. J., Heeringa, P., et al. (2007) Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium. Mol. Pharmacol. 72, 121-131. (Pubitemid 46998531)
17. Koning, G. A., Schiffelers, R. M., Wauben, M. H., Kok, R. J., Mastrobattista, E., et al. (2006) Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum. 54, 1198-1208. (Pubitemid 43672932)
18. Hirai, M., Minematsu, H., Kondo, N., Oie, K., Igarashi, K., et al. (2007) Accumulation of liposome with Sialyl Lewis X to inflammation and tumor region: application to in vivo bio-imaging. Biochem. Biophys. Res. Commun. 353, 553-558. (Pubitemid 46048704)
19. Ma, Z., Zhang, J., Alber, S., Dileo, J., Negishi, Y., et al. (2002) Lipid-mediated delivery of oligonucleotide to pulmonary endothelium. Am. J. Respir. Cell Mol. Biol. 27, 151-159. (Pubitemid 34780794)
20. van Meurs, M., Wulfert, F. M., Knol, A. J., De Haes, A., Houwertjes, M., et al. (2008) Early organ-specific endothelial activation during hemorrhagic shock and resuscitation. Shock. 29, 291-299.
21. Kok, R. J., Everts, M., Asgeirsdottir, S. A., Meijer, D. K., and, Molema, G., (2002) Cellular handling of a dexamethasone-anti-E-selectin immunoconjugate by activated endothelial cells: comparison with free dexamethasone. Pharm. Res. 19, 1730-1735. (Pubitemid 35305526)
22. Everts, M., Kok, R. J., Asgeirsdottir, S. A., Melgert, B. N., Moolenaar, T. J., et al. (2002) Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate. J. Immunol. 168, 883-889. (Pubitemid 34049592)
23. Everts, M., Koning, G. A., Kok, R. J., Asgeirsdottir, S. A., Vestweber, D., et al. (2003) In vitro cellular handling and in vivo targeting of E-selectin-directed immunoconjugates and immunoliposomes used for drug delivery to inflamed endothelium. Pharm. Res. 20, 64-72. (Pubitemid 36152919)
24. Muro, S., (2007) Adhesion molecule-1 and vascular cell adhesion molecule-1. In Endothelial Biomedicine (, Aird, W., ed.). pp. 1058-1070, Cambridge University press, New York.
25. Dallabrida, S. M., De Sousa, M. A., and, Farrell, D. H., (2000) Expression of antisense to integrin subunit beta 3 inhibits microvascular endothelial cell capillary tube formation in fibrin. J. Biol. Chem. 275, 32281-32288.
26. Brooks, P. C., Clark, R. A., and, Cheresh, D. A., (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 264, 569-571.
27. Schraa, A. J., Everts, M., Kok, R. J., Asgeirsdottir, S. A., Meijer, D. K., et al. (2002) Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases. Biotechnol. Annu. Rev. 8, 133-165. (Pubitemid 41081519)
28. Bartel, D. P., (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116, 281-297.
29. Garzon, R., Marcucci, G., and, Croce, C. M., (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug. Discov. 9, 775-789.
30. Rao, D. D., Vorhies, J. S., Senzer, N., and, Nemunaitis, J., (2009) siRNA vs. shRNA: similarities and differences. Adv. Drug Deliv. Rev. 61, 746-759.
31. Castanotto, D., and, Rossi, J. J., (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature. 457, 426-433.
32. Kaufmann, J., Ahrens, K., and, Santel, A., (2010) RNA interference for therapy in the vascular endothelium. Microvasc. Res. 80, 286-293.
33. Birmingham, A., Anderson, E., Sullivan, K., Reynolds, A., Boese, Q., et al. (2007) A protocol for designing siRNAs with high functionality and specificity. Nat. Protoc. 2, 2068-2078. (Pubitemid 351565844)
34. Bhindi, R., Fahmy, R. G., Lowe, H. C., Chesterman, C. N., Dass, C. R., et al. (2007) Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am. J. Pathol. 171, 1079-1088. (Pubitemid 47582883)
35. Kota, S. K., and, Balasubramanian, S., (2010) Cancer therapy via modulation of micro RNA levels: a promising future. Drug. Discov. Today. 15, 733-740.
36. Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., et al. (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 16, 909-914.
37. Molema, G., de Leij, L. F., and, Meijer, D. K., (1997) Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy. Pharm. Res. 14, 2-10. (Pubitemid 27113308)
38. Spragg, D. D., Alford, D. R., Greferath, R., Larsen, C. E., Lee, K. D., et al. (1997) Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc. Natl. Acad. Sci. USA. 94, 8795-8800. (Pubitemid 27335119)
39. Gerlag, D. M., Borges, E., Tak, P. P., Ellerby, H. M., Bredesen, D. E., et al. (2001) Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res. 3, 357-361. (Pubitemid 33077115)
40. Muro, S., Cui, X., Gajewski, C., Murciano, J. C., Muzykantov, V. R., etal. (2003) Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am. J. Physiol. Cell Physiol. 285, C1339-1347. (Pubitemid 37296311)
41. Bartsch, M., Weeke-Klimp, A. H., Meijer, D. K., Scherphof, G. L., and, Kamps, J. A., (2005) Cell-specific targeting of lipid-based carriers for ODN and DNA. J. Liposome Res. 15, 59-92. (Pubitemid 40976307)
42. Dykxhoorn, D. M., and, Lieberman, J., (2006) Knocking down disease with siRNAs. Cell 126, 231-235. (Pubitemid 44092975)
43. Behlke, M. A., (2008) Chemical modification of siRNAs for in vivo use. Oligonucleotides. 18, 305-319. (Pubitemid 352791344)
44. David, S., Pitard, B., Benoit, J. P., and, Passirani, C., (2010) Non-viral nanosystems for systemic siRNA delivery. Pharmacol. Res. 62, 100-114.
45. Simone, E., Ding, B. S., and, Muzykantov, V., (2009) Targeted delivery of therapeutics to endothelium. Cell Tissue Res. 335, 283-300.
46. Ogris, M., and, Wagner, E., (2002) Targeting tumors with non-viral gene delivery systems. Drug Discov. Today 7, 479-485. (Pubitemid 34532575)
47. Li, S. D., Chono, S., and, Huang, L., (2008) Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. J. Controlled Release 126, 77-84.
48. Masson, C., Garinot, M., Mignet, N., Wetzer, B., Mailhe, P., et al. (2004) pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery. J. Controlled Release 99, 423-434. (Pubitemid 39296911)
49. Li, J., and, Huang, L., (2010) Targeted delivery of RNAi therapeutics for cancer therapy. Nanomedicine (Lond) 5, 1483-1486.
50. Fenske, D. B., MacLachlan, I., and, Cullis, P. R., (2002) Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol. 346, 36-71. (Pubitemid 41103130)
51. Huang, L., Sullenger, B., and, Juliano, R., (2011) The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides. J.Drug Target. 18, 567-574.
52. Ding, B. S., Dziubla, T., Shuvaev, V. V., Muro, S., and, Muzykantov, V. R., (2006) Advanced drug delivery systems that target the vascular endothelium. Mol. Interv. 6, 98-112.
53. Eckstein, E. C., Tilles, A. W., and, Millero, F. J. III, (1988) Conditions for the occurrence of large near-wall excesses of small particles during blood flow. Microvasc. Res. 36, 31-39.
54. Charoenphol, P., Huang, R. B., and, Eniola-Adefeso, O., (2010) Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials. 31, 1392-1402.
55. Muro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., et al. (2008) Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther. 16, 1450-1458.
56. Kim, S. S., Garg, H., Joshi, A., and, Manjunath, N., (2009) Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol. Med. 15, 491-500.
57. Kamps, J. A., Morselt, H. W., Swart, P. J., Meijer, D. K., and, Scherphof, G. L., (1997) Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc. Natl. Acad. Sci. USA 94, 11681-11685. (Pubitemid 27451058)
58. Muro, S., Koval, M., and, Muzykantov, V., (2004) Endothelial endocytic pathways: gates for vascular drug delivery. Curr. Vasc. Pharmacol. 2, 281-299. (Pubitemid 38855034)
59. Kuruba, R., Wilson, A., Gao, X., and, Li, S., (2009) Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation. AAPS J. 11, 23-30.
60. Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V., et al. (2006) A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther. 13, 1222-1234. (Pubitemid 44184716)
61. Straley, K. S., and, Green, S. A., (2000) Rapid transport of internalized P-selectin to late endosomes and the TGN: roles in regulating cell surface expression and recycling to secretory granules. J. Cell Biol. 151, 107-116.
62. Muro, S., Wiewrodt, R., Thomas, A., Koniaris, L., Albelda, S. M., et al. (2003) A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J. Cell Sci. 116, 1599-1609. (Pubitemid 36527505)
63. Gluck, S. L., (1993) The vacuolar H(+)-ATPases: versatile proton pumps participating in constitutive and specialized functions of eukaryotic cells. Int. Rev. Cytol. 137C, 105-137. (Pubitemid 23204715)
64. Medina-Kauwe, L. K., Xie, J., and, Hamm-Alvarez, S., (2005) Intracellular trafficking of nonviral vectors. Gene Ther. 12, 1734-1751. (Pubitemid 41760286)
65. Adrian, J. E., Morselt, H. W., Suss, R., Barnert, S., Kok, J. W., et al. (2010) Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells. J. Controlled Release 144, 341-349.
66. Xu, Y., and, Szoka, F. C. Jr. , (1996) Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616-5623. (Pubitemid 26143656)
67. Zelphati, O., and, Szoka, F. C. Jr. , (1996) Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA 93, 11493-11498. (Pubitemid 26347149)
68. Wasungu, L., and, Hoekstra, D., (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. J. Controlled Release 116, 255-264. (Pubitemid 44854274)
69. Karanth, H., and, Murthy, R. S., (2007) pH-sensitive liposomes-principle and application in cancer therapy. J. Pharm. Pharmacol. 59, 469-483. (Pubitemid 47051120)
70. Sonawane, N. D., Szoka, F. C. Jr. , and, Verkman, A. S., (2003) Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278, 44826-44831. (Pubitemid 37377241)
71. Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., et al. (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7417.
72. Wu, S. Y., and, McMillan, N. A., (2009) Lipidic systems for in vivo siRNA delivery. AAPS J. 11, 639-652.
73. Gao, K., and, Huang, L., (2009) Nonviral methods for siRNA delivery. Mol. Pharm. 6, 651-658.
74. Schiffelers, R. M., Ansari, A., Xu, J., Zhou, Q., Tang, Q., et al. (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149.
75. van der, Gun, B. T., Monami, A., Laarmann, S., Rasko, T., Slaska-Kiss, K., et al. (2007) Serum insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2. J. Controlled Release 123, 228-238. (Pubitemid 350017779)
76. Asgeirsdottir, S. A., Talman, E. G., de Graaf, I. A., Kamps, J. A., Satchell, S. C., et al. (2010) Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro-a quantitative study. J. Controlled Release 141, 241-251.
77. Asgeirsdottir, S. A., Zwiers, P. J., Morselt, H. W., Moorlag, H. E., Bakker, H. I., et al. (2008) Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes. Am. J. Physiol. Renal Physiol. 294, F554-F561. (Pubitemid 351442225)
78. de Graaf, I. A., Olinga, P., de Jager, M. H., Merema, M. T., de, Kanter, R., et al. (2010) Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat. Protoc. 5, 1540-1551.
79. Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M., Kim, H. S., et al. (2010) Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin. Cancer Res. 16, 3910-3922.
80. Aleku, M., Fisch, G., Mopert, K., Keil, O., Arnold, W., et al. (2008) Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression. Cancer Res. 68, 9788-9798.
81. Miyawaki-Shimizu, K., Predescu, D., Shimizu, J., Broman, M., Predescu, S., et al. (2006) siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L405-413.
82. Auguste, D. T., Furman, K., Wong, A., Fuller, J., Armes, S. P., et al. (2008) Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes. J. Controlled Release 130, 266-274.